NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 51 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $456,000 | -3.0% | 337,000 | 0.0% | 0.06% | -1.5% |
| Q4 2020 | $470,000 | +1.5% | 337,000 | 0.0% | 0.07% | -17.5% |
| Q3 2020 | $463,000 | -17.3% | 337,000 | 0.0% | 0.08% | -11.1% |
| Q2 2020 | $560,000 | +29.6% | 337,000 | 0.0% | 0.09% | +28.6% |
| Q1 2020 | $432,000 | -16.3% | 337,000 | 0.0% | 0.07% | +34.6% |
| Q4 2019 | $516,000 | +11.9% | 337,000 | 0.0% | 0.05% | +10.6% |
| Q3 2019 | $461,000 | +4.3% | 337,000 | 0.0% | 0.05% | +9.3% |
| Q2 2019 | $442,000 | -2.9% | 337,000 | 0.0% | 0.04% | -4.4% |
| Q1 2019 | $455,000 | +60.8% | 337,000 | +42.2% | 0.04% | +45.2% |
| Q4 2018 | $283,000 | -30.0% | 237,000 | 0.0% | 0.03% | -11.4% |
| Q3 2018 | $404,000 | +18.1% | 237,000 | 0.0% | 0.04% | +16.7% |
| Q2 2018 | $342,000 | – | 237,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |